Trials / Completed
CompletedNCT02427373
A Parallel Bioavailability Study of Fish Oil-Ethyl Ester Versus Fish Oil-Triglyceride Versus Krill Oil
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- dsm-firmenich Switzerland AG · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
A multiple-dose, double-blind, randomized, four-week, three-treatment, parallel study in which 66 healthy adult subjects will receive 6 capsules/d, administered as a dose of 1.3 g/d eicosapentaenoic acid (EPA)+docosahexaenoic acid (DHA) in fish oil ethyl ester (EE), or fish oil triglyceride (TG) or krill oil for a total of 4 weeks. The objective of the study is to compare the oral bioavailability of EPA+DHA in total plasma across the three formulations at the end of the 4 week study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | fish oil ethyl ester | |
| DIETARY_SUPPLEMENT | fish oil triglyceride | |
| DIETARY_SUPPLEMENT | krill oil |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2014-08-01
- Completion
- 2014-12-01
- First posted
- 2015-04-28
- Last updated
- 2015-04-28
Source: ClinicalTrials.gov record NCT02427373. Inclusion in this directory is not an endorsement.